Active Commuters Have Lower Risks for Morbidity, Mortality
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 17, 2024 -- Active commuters who cycle or walk to work have lower risks for morbidity and mortality, according to a study published online July 16 in BMJ Public Health.
Catherine Friel, from the University of Glasgow in the United Kingdom, and colleagues examined prospective associations with multiple health outcomes over 18 years for pedestrians and cyclists using data for 82,297 individuals aged 16 to 74 years from the Scottish Longitudinal Study. Cyclist and pedestrian commuters were compared to nonactive commuters for a range of health outcomes.
The researchers found that cyclist commuting was associated with lower risks for all-cause mortality, any hospitalization, cardiovascular disease (CVD) hospitalization, and having a CVD prescription compared with nonactive commuting (hazard ratios, 0.53, 0.90, 0.76, and 0.70, respectively) and with lower risks for cancer mortality, cancer hospitalization, and having a prescription for mental health problems (hazard ratios, 0.49, 0.76, and 0.80, respectively). Pedestrian commuting was associated with lower risks for any hospitalization, CVD hospitalization, having a CVD prescription, and having a mental health prescription (hazard ratios, 0.91, 0.90, 0.90 and 0.93, respectively).
"These findings provide direct evidence of the health benefits of active commuting in a Scottish context, supporting current policy," the authors write. "This study has wider global relevance to efforts to reduce carbon emissions and to shift to more active and sustainable travel modes."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2024
Read this next
2020 to 2023 Saw Increase in Buprenorphine Dispensing for Teens
THURSDAY, Dec. 26, 2024 -- Buprenorphine dispensing increased among adolescents and decreased among young adults between 2020 and 2023, according to a research letter published...
Prevalence of Post-COVID-19 Condition in Adults 8.4 Percent in 2023
THURSDAY, Dec. 26, 2024 -- The prevalence of post-COVID-19 condition (PCC) was 8.4 percent among U.S. adults in 2023, according to a research letter published online Dec. 13 in...
COVID-19 Infection Not Linked to Changes in MS Symptom Severity
THURSDAY, Dec. 26, 2024 -- COVID-19 infection is not associated with immediate changes in multiple sclerosis (MS) symptom severity or disability, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.